Molecular Vision 2019; 25:843-850 <>
Received 25 April 2019 | Accepted 03 December 2019 | Published 05 December 2019

Common variants in the COL2A1 gene are associated with lattice degeneration of the retina in a Japanese population

Shinya Okazaki,1 Akira Meguro,1 Ryuichi Ideta,2 Masaki Takeuchi,1 Junichi Yonemoto,1 Takeshi Teshigawara,1,3,4 Takahiro Yamane,1 Eiichi Okada,5 Hidenao Ideta,2 Nobuhisa Mizuki1

1Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan; 2Ideta Eye Hospital, Kumamoto, Kumamoto, Japan; 3Yokosuka Chuoh Eye Clinic, Yokosuka, Kanagawa, Japan; 4Tsurumi Chuoh Eye Clinic, Yokohama, Kanagawa, Japan; 5Okada Eye Clinic, Yokohama, Kanagawa, Japan

Correspondence to: Akira Meguro, Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan; Phone: +81 45 787 2683; FAX: +81 45 781 9755; email:


Purpose: Lattice degeneration of the retina is a vitreoretinal disorder characterized by a visible fundus lesion that predisposes the patient to retinal detachment. It has been suggested that collagen type II alpha 1 (COL2A1) gene variants may contribute to the development of disorders associated with retinal detachment. Here we investigated whether COL2A1 gene variants were associated with the risk of lattice degeneration of the retina.

Methods: We recruited 634 Japanese patients with lattice degeneration of the retina and 1694 Japanese healthy controls. We genotyped 13 tagging single-nucleotide polymorphisms (SNPs) in COL2A1. We also performed imputation analysis to evaluate the potential association of un-genotyped COL2A1 SNPs, involving the imputation of 65 SNPs.

Results: Two intronic SNPs—rs1793954 and rs1635533—were significantly associated with lattice degeneration of the retina. The SNP rs1793954 showed the strongest association, with its C allele carrying an increased disease risk (p = 0.0016, corrected p = 0.021, OR = 1.25). The rs1793954 and rs1635533 SNPs were in strong linkage disequilibrium with each other (r2 = 0.99), and conditional analysis revealed that rs1793954 could account for the association between rs1635533 and the disease.

Conclusions: Our results suggested that COL2A1 gene variants may contribute to the development of lattice degeneration of the retina. Further genetic and functional analyses of COL2A1 variants are needed to clarify the present findings.


Lattice degeneration of the retina is a vitreoretinal disorder characterized by focal retinal thinning associated with liquefaction of the overlying vitreous gel and by firm vitreoretinal adherence to lesion margins [1,2]. After posterior vitreous detachment, vitreous traction at sites of substantial vitreoretinal adhesion often leads to retinal detachment [1,2]. Lattice degeneration is common in the general population, with reported prevalence rates of 6%–10.7% among Caucasians and Asians [1,3-5] and 1.8% among Africans [6]. In several ethnic populations, lattice degeneration is causally associated with 30%–60% of retinal detachment cases [7-11]. Lattice degeneration associated with retinal detachment is described in multiple hereditary disorders, including Stickler syndrome [12], Marfan syndrome [13], Ehlers-Danlos syndrome [14], and Wagner syndrome [15].

The exact pathophysiological mechanisms underlying lattice degeneration remain uncertain, but it is suggested that polygenic or multifactorial factors contribute to its etiology [16]. In 2012, we reported a genome-wide association study (GWAS) of lattice degeneration of the retina using 23,465 microsatellite markers in a Japanese population, in which we identified the collagen type IV alpha 4 (COL4A4) gene as a candidate susceptibility determinant [17]. Type IV collagen is the major structural component of the basement membranes that predominantly comprise the retinal structure; thus, we speculated that COL4A4 protein aberrations caused by genetic variants may promote retinal thinning in cases of retinal lattice degeneration. To date, our GWAS is the only genetic study to identify susceptibility genes for lattice degeneration.

Mutations in the collagen type II alpha 1 (COL2A1) gene are reportedly associated with rhegmatogenous retinal detachment (RRD), the most common type of retinal detachment [18,19]. Moreover, it is well known that COL2A1 mutations are associated with Stickler syndrome type I, which carries a high risk of RRD [20-22]. These findings suggest that COL2A1 variants may contribute to the development of inherited disorders associated with retinal detachment. However, our previous GWAS using microsatellite markers has not identified any significant association between COL2A1 variants and lattice degeneration of the retina [17]. Given that the GWAS has a poorer mapping resolution and lower detection power compared to GWAS using single-nucleotide polymorphisms (SNPs), it could have failed to assess properly the association between COL2A1 variants and lattice degeneration.

In the present study, we aimed to investigate the role of COL2A1 gene variants in the development of lattice degeneration of the retina. We performed a candidate gene approach to evaluate the association between COL2A1 SNPs and lattice degeneration in a Japanese population.



For this study, we enrolled 634 unrelated patients with lattice degeneration of the retina and 1,694 unrelated healthy controls, all of Japanese descent, and these numbers included all patients and controls used in our previous GWAS [17]. The subjects were recruited from Yokohama City University, Ideta Eye Hospital, Yonemoto Eye Clinic, Nanbu Hospital, and Okada Eye Clinic. Blood samples were collected from patients who were scheduled for surgery for retinal detachment caused by lattice degeneration. The study details were explained to all patients and controls, and written informed consent was obtained from all participants. The study methodology adhered to the tenets of the Declaration of Helsinki and was approved by the relevant ethics committees at each participating institute. Lattice degeneration was diagnosed by retina specialists using indirect ophthalmoscopy and scleral indentation. The criteria for a lattice degeneration diagnosis included one or more of the following observations: lattice-like white line changes in the crossing retinal vessels; snail-track variations; altered pigmentation; ovoid or linear reddish craters; localized round, oval, or linear retinal thinning; and attachment of condensed vitreous fibers to the lesion edges. Regardless of variations in pigmentation or other morphological features, a lesion was considered lattice degeneration if the examiner encountered an abrupt and discrete irregularity of an otherwise smooth retinal surface at the lesion border. The control subjects were all healthy volunteers, unrelated to each other or to the patients with lattice degeneration of the retina, and affected by neither lattice degeneration of the retina nor any local or systemic illnesses. All control subjects were confirmed as not having lattice degeneration through a dilated fundus examination, whereas whether their family members have lattice degeneration was not confirmed.

DNA and COL2A1 genotyping

From peripheral blood samples, we extracted genomic DNA using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany). Standardized conditions were used to maintain consistent DNA quality.

From the HapMap Phase III Japanese data (NCBI), we selected tagging SNPs that covered the COL2A1 region, including 5 kb upstream and downstream from the gene, and SNPs that had a minor allele frequency of ≥5% and a pairwise r2 value of ≥0.8. The chosen tagging SNPs were rs2071358, rs4760608, rs1793949, rs11168337, rs3829735, rs740024, rs2071437, rs12423250, rs1034762, rs1793958, rs1793953, rs12228854, and rs6580647. We performed SNP genotyping using the TaqMan 5′ exonuclease assay, with primers from Applied Biosystems (Foster City, CA). PCR was performed in a 10-μL reaction mixture containing 1× TaqMan Universal PCR Master Mix (Applied Biosystems), 24 nmol of each primer–probe set, and 3 ng genomic DNA. The PCR conditions included 95 °C for 10 min, followed by 40 cycles of denaturation at 92 °C for 15 s and annealing/extension at 60 °C for 1 min. The probe’s fluorescence signal was detected using the StepOnePlus Real-Time PCR System (Applied Biosystems).

Imputation analysis of the COL2A1 gene region

We also performed imputation analysis to evaluate potential associations with un-genotyped SNPs within the region 5 kb upstream and downstream from COL2A1. We imputed the genotypes of 634 cases and 1,694 controls using MACH v1.0 [23,24]. As a reference panel, we used the 1000 Genomes Phase 3 data sets of 504 East Asian samples, which included a set of Japanese samples from Tokyo (JPT, n = 104), Han Chinese samples from Beijing (CHB, n = 103), Southern Han Chinese samples (CHS, n = 105), Chinese Dai samples from Xishuangbanna (CDX, n = 93), and Kinh samples from Ho Chi Minh City (KHV, n = 99; 1000Genomes) [25]. All imputed SNPs were filtered using the following quality controls: Hardy–Weinberg equilibrium (HWE) p>0.001, minor allele frequency >1%, and a squared correlation between imputed and true genotypes (Rsq) >0.70. MACH recommends an Rsq threshold of >0.30 that can remove 70% of poorly imputed SNPs while retaining 99.5% of well-imputed SNPs [24]. In the present study, we used an Rsq threshold of >0.70 to filter out even more poorly imputed SNPs and perform association analysis with SNPs imputed at high quality. After the quality control filtering, we included the 65 imputed SNPs in further analysis.

Online database analysis

We investigated the functional roles of candidate SNPs using HaploReg v4.1 [26] and RegulomeDB [27]. To assess associations between candidate SNPs and the COL2A1 expression, we used the GTEx Portal online database [28].

Statistical analysis

Association analysis, stepwise regression analysis, and linkage disequilibrium (LD) estimation were performed using the SNP & Variation Suite software (version 8.6.0, Golden Helix, Inc., Bozeman, MT) and Haploview 4.2 software [29]. The obtained p values and odds ratios (ORs) were adjusted for spherical equivalent (SE; adjP and adjOR, respectively). The P and adjP values were corrected for multiple testing using the Bonferroni method based on the number of tagging SNPs (n = 13). A corrected P (Pc) and adjP (adjPc) values of <0.05 were considered significant. We generated a regional association plot for the COL2A1 region using LocusZoom [30].


Among the control participants, the genotype frequencies of all 13 tagging SNPs were in HWE (p>0.05). Figure 1 shows the results of allelic association tests for the 13 tagging and 65 imputed SNPs in COL2A1. Of these 78 SNPs, the strongest significant associations were with two imputed intronic SNPs, rs1793954 (p = 0.0016, Pc = 0.021) and rs1635533 (p = 0.0017, Pc = 0.023). Specifically, increased disease risk was associated with the C allele of rs1793954 (OR = 1.25) and the G allele of rs1635533 (OR = 1.24; Table 1, Figure 1). We also observed associations with two tagging SNPs, but these associations were not significant after correction: rs3829735, p = 0.0050, Pc = 0.065, OR = 1.45; and rs1793953, p = 0.0040, Pc = 0.053, OR = 1.22 (Table 1, Figure 1; Appendix 1). Another six imputed SNPs showed moderate but not significant associations (p<0.05, Pc >0.05; Table 1). The remaining 68 SNPs showed no significant risk association.

Lattice degeneration is commonly found in patients with myopia [1,7]. In the present study, the average SEs of the patients were −3.81±3.94 diopters (D; range, −20.00 to +3.75 D) in the right eye and −3.79±3.94 D (range, −22.00 to +3.50 D) in the left eye and 53.4% of the patients had a SEM less than −3.00 D. For the controls, the average SEs were 0.48±0.66 D (range, −1.00 to 3.50 D) in the right eye and 0.48±0.64 D (range, −1.00 to 3.00 D) in the left eye. To adjust for differences in SEM between the patients and controls, we performed a logistic regression analysis for each SNP. After adjusting for SE, rs1793954 and rs1635533 still showed significant associations with lattice degeneration of the retina (rs1793954: adjp = 0.0036, adjPc = 0.047, adjOR = 1.30; and rs1635533, adjp = 0.0038, adjPc = 0.049, adjOR = 1.29).

Figure 1 and Figure 2 illustrate the LD between the strongly associated SNP rs1793954 and all other SNPs in COL2A1. The SNP rs1793954 showed strong LD with the other significantly associated SNP rs1635533 (r2 = 0.99) and with the other four SNPs that showed p values of <0.05 (rs2023939, rs12308909, rs1635532, and rs1793953; r2 ≥0.59). On the other hand, rs1793954 exhibited low LD with the remaining four SNPs having p values of <0.05 (rs12721423, rs34829929, rs28594309, and rs3829735; r2 <0.10). Using the 10 SNPs showing p values <0.05, we performed stepwise regression analysis to test the independence of multiple possible associations in the COL2A1 region. Conditioning by SNP rs1793954 completely eliminated the associations of the other five SNPs that were in strong LD with rs1793954 (rs1635533, rs2023939, rs12308909, rs1635532, and rs1793953; p>0.70). These findings suggested that rs1793954 might account for the associations of the other SNPs with lattice degeneration of the retina in the Japanese population.

The HaploReg v4.1 database predicts that the SNP rs1793954 within the intron of COL2A1 is located in enhancer histone marks and alters the regulatory motif of an Evi-1 transcription factor. It also predicts that the rs1793954 C risk allele will show a much lower affinity to the transcription factor motif compared to its T allele, suggesting that rs1793954 has a potential role in regulating the COL2A1 expression. However, the RegulomeDB database shows that rs1793954 has a score of 5 with minimal binding evidence (indicating that it is unlikely to affect transcription factor binding), and the GTEx Portal database includes no reported significant association between rs1793954 and the COL2A1 expression.


The COL2A1 gene encodes the alpha 1 chain of type II collagen, which is a major component of cartilage and the vitreous of the eye [31-33]. It spans about 33 kb, with 54 exons on chromosome 12q13.11, and COL2A1 mutations are associated with RRD and Stickler syndrome type I [18-22]. Hoornaert et al. [21] demonstrated that COL2A1 loss-of-function mutations are the predominant cause of Stickler syndrome type I and vitreoretinal abnormalities (including vitreous anomalies and retinal tear or detachment) are more common in Stickler syndrome type I patients with COL2A1 mutation compared to those without a mutation. This evidence suggests that a COL2A1 mutation can lead to vitreoretinal abnormalities that are associated with the development of retinal detachment.

In the present study, we aimed to assess whether COL2A1 SNPs affected the development of lattice degeneration of the retina, which carries a high risk of RRD. We performed a comprehensive association analysis of SNPs in the COL2A1 region among Japanese patients with lattice degeneration of the retina. To our knowledge, this study was the first attempt to investigate the possible association between COL2A1 gene polymorphisms and lattice degeneration of the retina. Our findings demonstrated that the COL2A1 intronic SNP rs1793954 had a significant impact on disease development, with the C allele of rs1793954 associated with elevated disease risk. Spickett et al. [34] recently reported that another common intronic SNP rs1635532 was significantly associated with RRD in a white European population [34]. In our Japanese population, rs1635532 exhibited strong LD with rs1793954 (r2 = 0.95, Figure 2) and showed a moderate non-significant association with lattice degeneration of the retina (p<0.05, Pc >0.05). This suggested that the region showing strong LD and including rs1793954 may be an important locus for the development of RRD and RRD-associated disorders. Further validation studies in other ethnic populations are needed to clarify the association between the LD region and lattice degeneration of the retina.

Because non-coding variants can significantly affect gene expression [35], we assessed the functional role of rs1793954 in the COL2A1 expression. The HaploReg v4.1 database predicts that rs1793954 has a potential role in regulating the COL2A1 expression, with the risk allele C showing a much lower affinity to the transcription factor motif. Pathogenic features of lattice degeneration of the retina include vitreous humor liquefaction, loss of vitreoretinal attachments, loss of the internal limiting membrane over the lesions, and increased vitreoretinal attachment at the lesion margins. Therefore, the data from HaploReg v4.1 suggest that the vitreoretinal abnormalities in patients with lattice degeneration of the retina may arise from an altered COL2A1 expression associated with the rs1793954 C allele. However, other public databases show little or no evidence that rs1793954 significantly affects the COL2A1 expression. This inconsistent evidence highlights the necessity of further functional studies to clarify the contribution of COL2A1rs1793954 to the development of lattice degeneration of the retina.

In our present study, we targeted COL2A1 SNPs with a minor allele frequency of >1% to investigate the contribution of COL2A1 variants to the risk of lattice degeneration of the retina. However, most previous studies have reported rare COL2A1 mutations, particularly mutations in the exon regions, as causative variants of RRD and Stickler syndrome type I [18-22]. This suggests that rare COL2A1 mutations are also involved in the development of lattice degeneration of the retina. Therefore, there remains a need for mutation analyses of COL2A1 in patients with lattice degeneration of the retina. Another limitation to be considered is that the present study was conducted in only Japanese population. An association observed in one population often fails to replicate in other populations. Thus, further genetic association studies with other ethnic populations are required to validate the findings observed in the present study.

In conclusion, our current results revealed a significant association between the COL2A1 SNP rs1793954 and lattice degeneration of the retina in a Japanese population, suggesting that COL2A1 variants play important roles in disease development. Moreover, the present results suggest the possibility that rs1793954 contributes to an altered COL2A1 expression, which may be involved in the development of lattice degeneration of the retina. To validate these findings and to clarify the contribution of the COL2A1 region to disease development, further genetic analyses and functional analyses of COL2A1 variants should be performed.

Appendix 1. Allelic association results for 13 tag SNPs directly genotyped in this study.


We sincerely thank all the participants for their participation in this study, and all the medical staff involved in sample collection and diagnosis. This study was supported by a grant from the Yokohama Foundation for Advancement of Medical Science (no grant number available).


  1. Byer NE. Lattice degeneration of the retina. Surv Ophthalmol. 1979; 23:213-48. [PMID: 424991]
  2. Lewis H. Peripheral retinal degenerations and the risk of retinal detachment. Am J Ophthalmol. 2003; 136:155-60. [PMID: 12834683]
  3. Staatsma BR, Zeegen PD, Foos RY, Feman SS, Shabo AL. XXX Edward Jackson Memorial Lecture. Lattice degeneration of the retina. Trans Am Acad Ophthalmol Otolaryngol. 1974; 78:87-113. [PMID: 4605452]
  4. Byer NE. Clinical study of lattice degeneration of the retina. Trans Am Acad Ophthalmol Otolaryngol. 1965; 69:1065-81. [PMID: 5861646]
  5. Shiomi Y. Study of lattice degeneration of the retina. Part 2. Clinical features of lattice degeneration of the retina (author’s transl). Nippon Ganka Gakkai Zasshi. 1981; 85:269-75. [PMID: 7270351]
  6. Av-Shalom A, Berson D, Gombos GM, Landau L, Michaelson IC, Zauberman H. The vitreo-retinopathy associated with retinal detachment among Africans. Am J Ophthalmol. 1967; 64:387-91. [PMID: 6036297]
  7. Morse PH. Lattice degeneration of the retina and retinal detachment. Am J Ophthalmol. 1974; 78:930-4. [PMID: 4440727]
  8. Murakami-Nagasako F, Ohba N. Phakic retinal detachment associated with atrophic hole of lattice degeneration of the retina. Graefes Arch Clin Exp Ophthalmol. 1983; 220:175-8. [PMID: 6884779]
  9. Laatikainen L, Tolppanen EM. Characteristics of rhegmatogenous retinal detachment. Acta Ophthalmol (Copenh). 1985; 63:146-54. [PMID: 4003042]
  10. Törnquist R, Stenkula S, Törnquist P. Retinal detachment. A study of a population-based patient material in Sweden 1971–1981. I. Epidemiology. Acta Ophthalmol (Copenh). 1987; 65:213-22. [PMID: 3604613]
  11. Sasaki K, Ideta H, Yonemoto J, Tanaka S, Hirose A, Oka C. Epidemiologic characteristics of rhegmatogenous retinal detachment in Kumamoto, Japan. Graefes Arch Clin Exp Ophthalmol. 1995; 233:772-6. [PMID: 8626085]
  12. Carroll C, Papaioannou D, Rees A, Kaltenthaler E. The clinical effectiveness and safety of prophylactic retinal interventions to reduce the risk of retinal detachment and subsequent vision loss in adults and children with Stickler syndrome: a systematic review. Health Technol Assess. 2011; 15:iii-xiv.-, 1–62.. [PMID: 21466760]
  13. Hubbard AD, Charteris DG, Cooling RJ. Vitreolensectomy in Marfan’s syndrome. Eye (Lond). 1998; 12:412-6. [PMID: 9775242]
  14. Pemberton JW, Freeman HM, Schepens CL. Familial retinal detachment and the Ehlers-Danlos syndrome. Arch Ophthalmol. 1966; 76:817-24. [PMID: 5924938]
  15. Hirose T, Lee KY, Schepens CL. Wagner’s hereditary vitreoretinal degeneration and retinal detachment. Arch Ophthalmol. 1973; 89:176-85. [PMID: 4691317]
  16. Murakami F, Ohba N. Genetics of lattice degeneration of the retina. Ophthalmologica. 1982; 185:136-40. [PMID: 7133627]
  17. Meguro A, Ideta H, Ota M, Ito N, Ideta R, Yonemoto J, Takeuchi M, Uemoto R, Nishide T, Iijima Y, Kawagoe T, Okada E, Shiota T, Hagihara Y, Oka A, Inoko H, Mizuki N. Common variants in the COL4A4 gene confer susceptibility to lattice degeneration of the retina. PLoS One. 2012; 7:e39300 [PMID: 22723992]
  18. Go SL, Maugeri A, Mulder JJ, van Driel MA, Cremers FP, Hoyng CB. Autosomal dominant rhegmatogenous retinal detachment associated with an Arg453Ter mutation in the COL2A1 gene. Invest Ophthalmol Vis Sci. 2003; 44:4035-43. [PMID: 12939326]
  19. Richards AJ, Meredith S, Poulson A, Bearcroft P, Crossland G, Baguley DM, Scott JD, Snead MP. A novel mutation of COL2A1 resulting in dominantly inherited rhegmatogenous retinal detachment. Invest Ophthalmol Vis Sci. 2005; 46:663-8. [PMID: 15671297]
  20. Ahmad NN, Ala-Kokko L, Knowlton RG, Jimenez SA, Weaver EJ, Maguire JI, Tasman W, Prockop DJ. Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc Natl Acad Sci USA. 1991; 88:6624-7. [PMID: 1677770]
  21. Hoornaert KP, Vereecke I, Dewinter C, Rosenberg T, Beemer FA, Leroy JG, Bendix L, Björck E, Bonduelle M, Boute O, Cormier-Daire V, De Die-Smulders C, Dieux-Coeslier A, Dollfus H, Elting M, Green A, Guerci VI, Hennekam RC, Hilhorts-Hofstee Y, Holder M, Hoyng C, Jones KJ, Josifova D, Kaitila I, Kjaergaard S, Kroes YH, Lagerstedt K, Lees M, Lemerrer M, Magnani C, Marcelis C, Martorell L, Mathieu M, McEntagart M, Mendicino A, Morton J, Orazio G, Paquis V, Reish O, Simola KO, Smithson SF, Temple KI, Van Aken E, Van Bever Y, van den Ende J, Van Hagen JM, Zelante L, Zordania R, De Paepe A, Leroy BP, De Buyzere M, Coucke PJ, Mortier GR. Stickler syndrome caused by COL2A1 mutations: genotype-phenotype correlation in a series of 100 patients. Eur J Hum Genet. 2010; 18:872-80. [PMID: 20179744]
  22. Barat-Houari M, Sarrabay G, Gatinois V, Fabre A, Dumont B, Genevieve D, Touitou I. Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies. Hum Mutat. 2016; 37:7-15. [PMID: 26443184]
  23. Li Y, Willer CJ, Sanna S, Abecasis G. Genotype Imputation. Annu Rev Genomics Hum Genet. 2009; 10:387-406. [PMID: 19715440]
  24. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010; 34:816-34. [PMID: 21058334]
  25. 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012; 491:56-65. [PMID: 23128226]
  26. Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016; 44:D877-81. [PMID: 26657631]
  27. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, Cherry JM, Snyder M. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012; 22:1790-7. [PMID: 22955989]
  28. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013; 45:580-5. [PMID: 23715323]
  29. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21:263-5. [PMID: 15297300]
  30. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, Boehnke M, Abecasis GR, Willer CJ. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010; 26:2336-7. [PMID: 20634204]
  31. Cheah KS, Stoker NG, Griffin JR, Grosveld FG, Solomon E. Identification and characterization of the human type II collagen gene (COL2A1). Proc Natl Acad Sci USA. 1985; 82:2555-9. [PMID: 3857598]
  32. Miller EJ, Gay S. The collagens: an overview and update. Methods Enzymol. 1987; 144:3-41. [PMID: 3306286]
  33. Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res. 2000; 19:323-44. [PMID: 10749380]
  34. Spickett C, Hysi P, Hammond CJ, Prescott A, Fincham GS, Poulson AV, McNinch AM, Richards AJ, Snead MP. Deep Intronic Sequence Variants in COL2A1 Affect the Alternative Splicing Efficiency of Exon 2, and May Confer a Risk for Rhegmatogenous Retinal Detachment. Hum Mutat. 2016; 37:1085-96. [PMID: 27406592]
  35. Wang D, Guo Y, Wrighton SA, Cooke GE, Sadee W. Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs. Pharmacogenomics J. 2011; 11:274-86. [PMID: 20386561]